Vandalia Health cardiologists in Morgantown performed West Virginia’s first pulsed field ablation using the FARAPOINT catheter, a minimally invasive approach for AFib and other arrhythmias that uses ...

A revolutionary non-surgical treatment developed at University Hospital Southampton is helping to transform care for kidney ...

This medical device innovator for cardiac surgery reported a notable insider sale amid a year of negative total returns.

Pulse Biosciences (Nasdaq:PLSE) announced a new strategic alignment to focus on its nPulse cardiac catheter ablation system.

Pulse Biosciences, Inc. (Nasdaq: PLSE), pioneer of the novel nPulse™ platform using proprietary Nanosecond Pulsed Field Ablation (nsPFA™), today announced a new strategic alignment to prioritize and ...

The CAPTAIN trial shows faster recovery, fewer complications, and better early function with the minimally invasive therapy in men with intermediate-risk prostate cancer.

For patients with obesity and atrial fibrillation (Afib), GLP-1 receptor agonist drugs may be the weight loss approach that better addresses their arrhythmia, observational data suggested.

ACCESS GPO today announced a preferred, multi-year agreement with Medtronic to support availability of the Affera(TM) Mapping and Ablation System with Sphere-9(TM) Catheter in ambulatory surgery ...

First multicenter, randomized controlled trial directly comparing a new technology to robotic RP for men with localized prostate cancer to ...

Patients treated with microwave ablation experienced significantly fewer postoperative complications and shorter hospital stays.

Quantum Surgical is looking to become the “leader in the interventional radiology industry” with its buyout of Johnson & Johnson’s cancer ablation company NeuWave Medical. The France-based cancer ...